| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 5.91M | 6.56M | 13.20M | 22.77M |
| Gross Profit | 2.17M | 2.56M | 5.65M | 9.45M |
| EBITDA | -6.48M | -2.12M | 2.30M | 6.37M |
| Net Income | -6.66M | -2.29M | 2.18M | 6.22M |
Balance Sheet | ||||
| Total Assets | 7.74M | 5.08M | 9.71M | 15.25M |
| Cash, Cash Equivalents and Short-Term Investments | 2.79M | 2.10M | 5.16M | 6.19M |
| Total Debt | 2.07M | 907.45K | 400.00K | 410.88K |
| Total Liabilities | 3.56M | 1.91M | 910.27K | 1.24M |
| Stockholders Equity | 4.18M | 3.17M | 8.80M | 14.01M |
Cash Flow | ||||
| Free Cash Flow | -5.23M | 494.19K | 6.51M | 8.94M |
| Operating Cash Flow | -4.61M | 540.35K | 7.00M | 9.36M |
| Investing Cash Flow | -616.90K | -46.17K | -490.02K | -422.49K |
| Financing Cash Flow | 5.21M | -3.55M | -7.54M | -4.57M |
Beginning January 28, 2026, Callan JMB Inc. plans to deliver a series of investor presentations at the DealFlow Discovery Conference and use the same materials in subsequent meetings with potential investors, industry analysts and other stakeholders. The company has made the investor presentation available on its website’s investor relations section and signaled that future presentations will routinely be accessible both online and through current reports, highlighting an effort to formalize and regularize its investor communications while emphasizing that the information is supplemental to its SEC filings and not necessarily indicative of material developments.
The most recent analyst rating on (CJMB) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.
At its virtual annual meeting of shareholders held on December 29, 2025, Callan JMB Inc., a Nevada corporation, reported that approximately 68.6% of its outstanding common shares were represented, either virtually or by proxy. Shareholders elected five directors—Wayne Williams, Eric Kash, Mark Meller, Liberty Duke, and Gerald Dial—to serve one-year terms expiring at the 2026 annual meeting, and ratified the appointment of Rosenberg Rich Baker Berman, P.A. as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, reinforcing continuity in both board leadership and external audit oversight.
The most recent analyst rating on (CJMB) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.
On December 8, 2025, Callan JMB Inc., a Nevada corporation, announced an amendment to its insider trading policy. The update changes the blackout period to start on the 20th day of the third calendar month of each fiscal quarter, extending until the first full trading day after the company’s financial results are publicly disclosed. This adjustment aims to align the policy with the company’s financial reporting schedule, potentially impacting how stakeholders engage with the company’s stock.
The most recent analyst rating on (CJMB) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.
Callan JMB, Inc., a Nevada-based company, has appointed Christopher Shields as the Interim Chief Financial Officer and Treasurer effective December 1, 2025. Shields, who has been with the company since April 2025 as Senior Vice President of Governmental Affairs, brings extensive experience from his previous role at the Chicago Department of Public Health. The company has not yet determined any changes to Shields’s compensation, but he will continue his current duties alongside the new role, with an annual base salary and potential incentive bonuses.
The most recent analyst rating on (CJMB) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.